Alector (ALEC) Operating Expenses (2018 - 2026)
Alector's (ALEC) quarterly Operating Expenses came in at $27.7 million in Q2 2026, down 34.04% year-over-year from $42.0 million in Q2 2025, and up 6.73% quarter-over-quarter from $26.0 million in Q1 2026.
Analysis
Alector (ALEC) Operating Expenses (2018 - 2026) Analysis & Trends
Alector (ALEC) has reported Operating Expenses for 9 consecutive years, with $27.7 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Operating Expenses fell 34.04% year-over-year to $27.7 million in Q2 2026; TTM through Jun 2026 was $140.3 million, a 34.92% decrease from a year earlier, with the FY2025 full-year figure at $177.1 million, down 27.9% from the prior year.
- Operating Expenses was $27.7 million for Q2 2026 at Alector, up from $26.0 million in the prior quarter.
- Over five years, Operating Expenses peaked at $70.4 million in Q2 2022 and troughed at $26.0 million in Q1 2026.
- A 5-year average of $55.4 million and a median of $60.2 million in 2023 frame the typical range for Operating Expenses.
- Across the five-year window, Operating Expenses increased 20.89% in 2022 and tumbled 46.32% in 2026, its largest moves.
- Over 5 years, Operating Expenses stood at $69.9 million in 2022, then dropped by 10.42% to $62.6 million in 2023, then dropped by 1.84% to $61.5 million in 2024, then declined by 25.51% to $45.8 million in 2025, then sank by 39.5% to $27.7 million in 2026.
- The last three Operating Expenses figures came in at $27.7 million (Q2 2026), $26.0 million (Q1 2026), and $45.8 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | 6.54 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | 18.20 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | 2.09 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 3.00 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | -1.05 Bn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | 960.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | 1.06 Bn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | 2.60 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Alector | 274.68 Mn | 101.88 Mn | - | 27.71 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 27.71 Mn |
| Mar 31, 2026 | 25.97 Mn |
| Dec 31, 2025 | 45.80 Mn |
| Sep 30, 2025 | 40.87 Mn |
| Jun 30, 2025 | 42.01 Mn |
| Mar 31, 2025 | 48.37 Mn |
| Dec 31, 2024 | 61.49 Mn |
| Sep 30, 2024 | 63.78 Mn |
| Jun 30, 2024 | 60.69 Mn |
| Mar 31, 2024 | 59.60 Mn |
| Dec 31, 2023 | 62.64 Mn |
| Sep 30, 2023 | 59.69 Mn |
| Jun 30, 2023 | 59.80 Mn |
| Mar 31, 2023 | 66.66 Mn |
| Dec 31, 2022 | 69.93 Mn |
| Sep 30, 2022 | 62.60 Mn |
| Jun 30, 2022 | 70.38 Mn |
| Mar 31, 2022 | 68.60 Mn |
| Dec 31, 2021 | 69.72 Mn |
| Sep 30, 2021 | 56.08 Mn |